Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bimatoprost in Primary Open Angle Glaucoma and Ocular Hypertension
NCT02061683Phase 4Completed
- Sponsor
- Allergan
- Start
- Apr 2010
- Primary completion
- Jun 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of bimatoprost in primary open-angle glaucoma (POAG) and ocular hypertension, sponsored by Allergan. Primary endpoint: Intraocular Pressure at 3 months. Started Apr 2010; status: completed.
02
Drugs
bimatoprost
03
Conditions
primary open-angle glaucoma (POAG)ocular hypertension
Beyond the preview
Go deeper on NCT02061683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02061683.